financetom
Business
financetom
/
Business
/
Thomson Reuters reports higher third-quarter revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Thomson Reuters reports higher third-quarter revenue
Nov 4, 2025 4:04 AM

Nov 4 (Reuters) - Thomson Reuters ( TMSOF ) reported

higher revenue for the third quarter on Tuesday, boosted by

investments in artificial intelligence products in its legal and

tax and accounting divisions.

The Toronto-based content and technology company

reaffirmed its full year 2025 guidance of a 7% to 7.5% rise in

organic revenue, which tracks income from existing businesses on

a constant currency basis.

"Our third-quarter results reflect continued momentum and

the ongoing execution of our AI-driven innovation strategy,"

Thomson Reuters ( TMSOF ) Chief Executive Steve Hasker said in a statement

after the results were released.

The owner of Westlaw legal database, Reuters news agency and

the Checkpoint tax and accounting service reported third-quarter

adjusted earnings per share of 85 cents, exceeding Wall Street

expectations, according to LSEG data.

Revenue rose 3% to $1.78 billion, meeting expectations.

Up to Monday's market close, Thomson Reuters ( TMSOF ) shares have

fallen about 5.4% this year, underperforming the 16.5% rise in

the S&P 500 index, which has been boosted by increases in

AI-heavy big tech stocks.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jyong Biotech to Evaluate Licensing Deal for MCS-2 Drug Candidate in South Korea
Jyong Biotech to Evaluate Licensing Deal for MCS-2 Drug Candidate in South Korea
Nov 24, 2025
10:08 AM EST, 11/24/2025 (MT Newswires) -- Jyong Biotech ( MENS ) said Monday that it signed a non-binding letter of intent with a South Korean pharmaceutical company to assess the potential in-licensing and development of Jyong Biotech's ( MENS ) MCS-2 candidate in South Korea. The company said definitive terms are still being negotiated and the LOI remains subject...
BlackRock, AccessFintech Form Partnership to Enhance Post-Trade Collaboration
BlackRock, AccessFintech Form Partnership to Enhance Post-Trade Collaboration
Nov 24, 2025
10:08 AM EST, 11/24/2025 (MT Newswires) -- BlackRock ( BLK ) and AccessFintech said Monday they have entered a partnership to integrate AccessFintech's Synergy Network with BlackRock's ( BLK ) Aladdin platform to enhance post trade collaboration between buy-side firms and more than 250 capital markets and asset servicing institutions. The companies said the partnership will provide better bilateral connectivity,...
Newmark Buys Catella Valuation Advisory
Newmark Buys Catella Valuation Advisory
Nov 24, 2025
10:10 AM EST, 11/24/2025 (MT Newswires) -- Newmark ( NMRK ) said Monday it acquired Catella Valuation Advisory, a French real estate valuation and advisory firm that operates in assets like office, retail, industrial, residential, and others. Financial terms of the acquisition were not provided. The entire Catella Valuation Advisory team will join Newmark ( NMRK ) in the coming...
Form 8.3
Form 8.3
Nov 24, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if...
Copyright 2023-2026 - www.financetom.com All Rights Reserved